In this cohort study, there was no survival difference at 15 years among older patients who underwent mechanical prosthetic vs bioprosthetic mitral replacement.
This retrospective cohort analysis quantifies survival and major morbidity in patients aged 50 to 69 years receiving bioprosthetic vs mechanical aortic valve replacement.
Dvir and coauthors evaluated data from a multinational valve-in-valve implantation registry to determine survival among patients after transcatheter valve-in-valve implantation inside failed surgical bioprosthetic valves.
In a randomized clinical trial involving 241 patients undergoing transcatheter aortic valve replacement, Abdal-Wahab and co-authors found that use of balloon-expandable valves resulted in a greater rate of device success than use of self-expandable valves.
To report the initial US experience with newly approved transcatheter aortic valve replacement, Mack and coauthors gathered outcome data, including all-cause in-hospital mortality and stroke, from 7710 cases in 224 participating US registry hospitals. Bonow comments in an editorial.
You currently have no searches saved.